Page last updated: 2024-08-23

s-2678 and Hepatoblastoma

s-2678 has been researched along with Hepatoblastoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Annis, DA; Badachhape, A; Chen, Z; Ghaghada, KB; Ibarra, AM; Larson, SR; López-Terrada, D; Patel, RH; Sarabia, SF; Shah, AP; Shi, Y; Srivastava, RK; Starosolski, Z; Sumazin, P; Vasudevan, SA; Whitlock, RS; Woodfield, SE	1

Other Studies

1 other study(ies) available for s-2678 and Hepatoblastoma

Article	Year
MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma. Scientific reports, 2021, 02-03, Volume: 11, Issue:1 Topics: Animals; Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Child, Preschool; Cohort Studies; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Hepatoblastoma; Humans; Liver; Liver Neoplasms; Male; Mice; Oxadiazoles; Piperazines; Proto-Oncogene Proteins; Signal Transduction; Tumor Suppressor Protein p53; Up-Regulation; Xenograft Model Antitumor Assays	2021

Article

Year

MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma.

Scientific reports, 2021, 02-03, Volume: 11, Issue:1

Topics: Animals; Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Child, Preschool; Cohort Studies; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Hepatoblastoma; Humans; Liver; Liver Neoplasms; Male; Mice; Oxadiazoles; Piperazines; Proto-Oncogene Proteins; Signal Transduction; Tumor Suppressor Protein p53; Up-Regulation; Xenograft Model Antitumor Assays

2021